Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: Uncategorized

Mifepristone remains available in US until midnight on 19 April

Justice Samuel Alito of the US Supreme Court ruled on 14 April that mifepristone, a drug used in […]

April 18, 2023 Uncategorized

Macomics reveals pivotal ENIGMAC data

Drug discovery platform is a tool specifically designed for gene-to-function studies using human macrophages

April 18, 2023 Uncategorized

ICR in research partnership with NeoPhore

Collaboration will further boost its promising pipeline of cancer treating therapies

April 18, 2023 Uncategorized

MinervaX begins critical GBS vaccine trial

Group B streptococcus vaccine study will involve adult groups with and without underlying conditions

April 17, 2023 Uncategorized

Immutep reveals commencement of vital phase 2 trial

Efti’s targeting activation of antigen-presenting cells delivers an adaptive immunity to fight cancer

April 17, 2023 Uncategorized

Biomodal releases genetics and epigenetics solution

Product delivers epigenetic information from a single low-input DNA library without medical treatment

April 14, 2023 Uncategorized

SynaptixBio receives incurable disease research boost

The Oxford-based biotech company has secured £13.2m to progress world’s vital treatment development

April 14, 2023 Uncategorized

Enhertu accepted for use across NHS Scotland

Decision will create opportunity for therapy to be used earlier in the treatment pathway

April 13, 2023 Uncategorized

Oxford University malaria vaccine gets Ghana green light

Notable first clearance for R21/Matrix-M malaria vaccine for use in a specific country

April 13, 2023 Uncategorized

Almirall analyses wider well-being in dermatology study

The trial will monitor patients across Europe for 24 months as they are treated with tildrakizumab

April 12, 2023 Uncategorized

Posts navigation

Posts pagination

« Previous 1 … 362 363 364 … 1,468 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy